Skip to main content
Compass Therapeutics, Inc. logo

Compass Therapeutics, Inc. — Investor Relations & Filings

Ticker · CMPX ISIN · US20454B1044 US Manufacturing
Filings indexed 334 across all filing types
Latest filing 2024-09-03 Regulatory Filings
Country US United States of America
Listing US CMPX

About Compass Therapeutics, Inc.

https://www.compasstherapeutics.com/

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company that develops proprietary antibody-based therapeutics. The company leverages its proprietary antibody discovery engine and in vitro/in vivo platforms to generate diverse antibody panels. This approach is based on a deep understanding of the tumor microenvironment, aiming to develop product candidates that optimize the immune system's anti-tumor response. The company's mission is to create transformative cancer therapies to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings
2024-09-03 English
S-3
Regulatory Filings
2024-08-30 English
Director's Dealing 2024
Director's Dealing
2024-08-14 English
FORM 10-Q
Interim / Quarterly Report Q2 2024
2024-08-12 English
FORM 8-K
Regulatory Filings
2024-08-12 English
Director's Dealing 2024
Director's Dealing
2024-08-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.